The ORCHESTRA project, launched in Dec 2020, has a vision to efficiently generate rigorous evidence to improve the prevention and treatment of COVID-19 and to rapidly provide a structured platform to test vaccines as soon as they are available.
ORCHESTRA project provides an innovative approach to learn from the SARS-CoV-2 health crisis and derive recommendations for increasing preparedness for future outbreaks.
The main outcome of the project is the creation of a new pan-European cohort, that will consist of both existing and new large-scale population cohorts from European and non-European countries.
The ORCHESTRA cohort will include SARS-CoV-2 infected and non-infected individuals of all ages and conditions. This will enable a retrospective evaluation of risk factors for the disease acquisition and progression, with a prospective follow-up aimed at exploring long term consequences and analysis of vaccination response.
As a beneficiary of the project, Penta will grant its scientific contribution in elaborating and analysing data of the paediatric cohorts included in the project. Additionally, it will contribute to the ORCHESTRA fragile population cohorts with pregnancy and pediatric cohorts across its network.
ORCHESTRA is funded by Horizon 2020